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Their ImprintA recent study has revealed that loss of neuronal expression of the paternally
imprinted gene Ube3a in Angelman syndrome results in selective neuronal loss
of robust circadian oscillations, with a resulting behavioural phenotype, and
adipose tissue accumulation.David W. Ray
Life evolved on Earth under conditions
of marked environmental oscillation:
cyclical transitions from day to night.
Under these conditions complex life
apportioned specific activities to
particular phases, for example
photosynthesis during the light phase,
or sleep during the dark phase.
However, such adaptations were
driven by internal rhythms, rather than
being a mere reaction to the change in
environment; i.e., a biological clock. In
a recent study reported in this issue
of Current Biology from Shi et al. [1]
new insights have been gained into
how the biological clock is controlled,
and with what consequences for
behavior.
The molecular basis of the circadian
(circa; about, diem; day) clock has been
elucidated, and the current model is of
a transcriptional and translational
feedback loop. This now includesmany
different molecular components, some
of which are rhythmically expressed, or
modified, and which participate in
feedback loops to modulate one
another’s expression. The core circuit
involves an activating arm provided by
the bHLH-PAS transcription factor
BMAL1/ARNTL, which dimerises with
CLOCK, or NPAS2. The heterodimeric
transcription factor activatesexpression of components of the
repressive feedback arm of the clock,
namely, PERIOD and
CRYPTOCHROME.
A core requirement for the clock to
work is that at least one central clock
component shows a rhythmic change
in abundance of activity. Indeed, both
PERIOD and CRYPTOCHROME
proteins shows a rhythmic oscillation.
Ubiquitinylation of CRYPTOCHROME,
with resulting effects on protein
turnover and circadian period, has
been discovered to be due to the F-box
proteins Fbxl3 and Fbxl21. However,
it was not thought that BMAL1
oscillation was required for core clock
function, or that such a regulatory
pathway existed. However, a
ubiquitinylation pathway mediated
by Ube3a that regulates BMAL1
abundance and affects clock function
was revealed recently in vitro.
Ube3a is encoded on human
chromosome 15q11-q13. This is of
interest as deletions of the maternal
copy of chromosome 15 in this
region are causative for the
complex neurodevelopmental
disorder Angelman syndrome (AS).
AS is characterized by a
neurodevelopmental defect resulting
in motor impairments, learning
difficulties, epilepsy, and sleep
disorders [2,3]. There is no treatment,and management is targeted at
symptom control, with most patients
requiring medication to control
epilepsy. AS results from genomic
imprinting, as the paternal allele is
imprinted, and so not expressed.
Therefore, loss of the maternal allele
results in loss of Ube3a expression
in tissues affected by the imprinting.
In AS, paternal imprinting is only
seen in the brain, so loss of Ube3a
expression is seen only in brain
neurons, and not glia or peripheral
tissues [4]. These observations
suggest a fascinating mechanistic link
between loss of neuronal Ube3a
expression, leading to altered BMAL1
ubiquitinylation [5] and stability, and
circadian disruption, leading to sleep
disturbance, specifically short sleep
duration and increased sleep onset
latency.
In the study reported in this issue
Shi et al. [1] identify a causal link
between Ube3a expression and
circadian rhythm in mouse models
of AS. They report weakened
rhythms in vivo, which is manifest
by more rapid re-setting of the
circadian oscillation to changes in
environmental light timing, an
experimental model of jet lag or shift
work. Similarly, under constant light
conditions the AS model animals show
an accelerated decay in rhythmic
behavior.
Analyses of tissue ex vivo by Shi
et al. provided new insight into the
causative mechanisms of AS in their
model animals. While no detectable
differences in circadian oscillations in
peripheral tissues were seen in AS
animals compared to controls, the
central brain clock located in the
suprachiasmatic nucleus had a
SLEEP WAKE
REST   ACTIVE Energy expenditure
Ube3a
E6-AP
Ub
BMAL1 
BMAL1::CLOCK PER::CRY
Current Biology
BMAL1 
Energy conservation
Figure 1. The imprinted gene Ube3a controls BMAL1 protein stability and thereby circadian
control of sleep and activity.
The paternally imprinted gene Ube3a encodes the Ubiquitin ligase E6-AP, which targets
BMAL1 for degradation. Loss of neuronal Ube3a expression resulting from maternal allele
loss causes BMAL1 stabilisation, disruption of circadian oscillation, and disturbance of sleep.
As is often seen with circadian disruption there is a fat accumulation phenotype, possibly due
to reduced energy expenditure.
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accompanying reduction in damping
rate. These data thus suggest a
core circadian oscillator problem,
and one restricted to neural
structures. As mentioned, the defect
in Ube3a expression results from
silencing of the paternal allele. But
by using a topoisomerase inhibitor,
which opens the targeted chromatin
and makes it permissive for
transcription, it is possible to reverse
this silencing. Indeed, Shi et al.
showed that such treatment restored
circadian period in brain slice cultures
from AS mice [1]. Such a novel
pharmacological approach to targeting
clock defects opens up attractive
new avenues for both scientific
exploration, but also therapeutic
application.A consistent and robust connection
has emerged between defects in the
core circadian machinery, or
environmental disruption of circadian
function, and important physiological
functions, such as energy homeostasis
[6] and immunity [7]. It appears that the
switch from fed to fasted states is
tightly controlled by the central clock,
and requires coordination between
food seeking behaviours, digestion,
and energy partitioning between liver,
muscle, and adipose tissue. And as
shown by Shi et al., disruption of
brain Ube3a expression in the AS
mouse model in turn results in
increased adipose tissue deposition.
This was not accompanied by
changes in energy intake, and did not
require a high-energy or high-fat diet.
However, the AS mice did showreduced overall activity with a change
in the timing of peak movement to
later in the dark period than typically
seen in wild-type mice [1]. Therefore,
fat accumulation may have resulted
from reduced overall energy
consumption, although the neural
mechanisms underlying this change
remain unclear.
These new observations provide new
insights into the operation of the
transcriptional–translational core
clock. The rhythmic abundance of
PERIOD and CRYPTOCHROME
proteins is essential for clock
oscillation, but BMAL1 variation
was not thought to be required.
However, as loss of Ube3a results in
stabilization of BMAL1 protein and
prolongation of the circadian period
with resulting weakening of the
cellular circadian oscillator, this
assumption is challenged. It is counter
intuitive that stabilizing BMAL1 protein
would result in a weak oscillation.
However, important recent
observations suggest that some
nutritional inputs to the cellular clock
also act by regulating BMAL1 protein
stability [8]. Taken together these
discoveries suggest that the positive
arm of the clock is indeed sensitive to
environmental change, and that such
effects are not restricted to the
negative arm (i.e., PERIOD and
CRYPTOCHROME) as previously
thought (see Figure 1 for a potential
mechanism).
A further intriguing suggestion is that
the sleep disruption seen in AS patients
may be a direct result of central
circadian disruption and that
appropriate environmental cues could
offer an attractive means to
therapeutically intervene. Such an
initiative might be expected to not only
offer low risk benefit to the
management of sleep disruption for the
affected patients and their careers, but
also have an impact on the obesity
phenotype seen in AS, and the related
Ube3a imprinting disorder Prader-Willi
syndrome.References
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LampreyThe function of the motor cortex has been a persistent mystery. A recent study
has found striking correspondence between the descending projections of
lamprey pallium and mammalian motor cortex, encouraging comparative
studies of the origin (and role) of forebrain motor control.Gonc¸alo Lopes and Adam R. Kampff*
Motor cortex is a confusing part of
cortex: over a hundred years of
research [1–6] has implicated motor
cortex in the control of movement, but
when it is completely removed most
mammals recover to perform much of
their behavioural repertoire [7,8].
Some of this recovery can be
attributed to the brain’s plasticity [9],
but are there aspects of behaviour for
which motor cortex is absolutely
required?
Some clarity has emerged from
studying primates. When motor cortex
is lesioned in primates (including
humans), a long-lasting deficit in
dexterous movement results [10,11].
However, these same dexterity deficits
can be induced by severing the direct
projection from motor cortex to spinal
cord [4], which is by no means the only
pathway from cortex to movement
(Figure 1). Motor cortex targets many
other brain regions that can themselves
generate movement. In fact, the direct
connection from cortex to spinal cord
appeared only recently in vertebrate
evolution, and was further elaborated
to include a direct connection from
cortex to motor neurons in only some
primate species [12]. In other
mammals, such as rodents, the
cortex’s projection to spinal cord does
not contact motor neurons [13] and
largely avoids ventral (motor) spinal
cord [6,14]. It thus seems likely that
most mammals rely on ‘indirect’
pathways to convey cortical motorcommands to spinal cord. What
movements do these pathways
control? What is their function? These
are important questions for which
many patients suffering from motor
cortical stroke, and experiencing more
than just deficits of dexterity, are
looking to neuroscientists for
answers [15].
We can gain insight into the origin
and role of cortical motor projections
by studying the extant (current) form of
mammalian relatives — birds, reptiles,
amphibians and so on — and the
homologous brain region, the pallium.
But how ‘far back’ in evolution can we
go? In a study published recently in
Current Biology, Ocan˜a et al. [16]
investigated whether a primordial
pallial motor centre was already
present in one of our most distant
vertebrate relatives: the lamprey.
The lamprey lineage diverged from
its fellow vertebrates more than half a
billion years ago [17]. Remarkably,
these distant relatives retain many
common structures, including those
responsible for movement: spinal
circuits for generating the basic
dynamics [18], reticulospinal centres
directing fixed action patterns [19], and
midbrain nuclei — for example, the
mesencephalic locomotor region
(MLR) and tectum — responsible for
the control of locomotion and
orientation. In mammals, the forebrain
has asserted itself in the control of
movement, and the motor regions of
cortex have long been considered
necessary for the skilled, dexterousmovements that are characteristic of
mammals. Does such a pallial (cortical)
motor control structure exist in the
lamprey?
Ocan˜a et al. [16] set out to identify
and characterize the forebrain motor
centres of the lamprey pallium using a
suite of functional and anatomical
methods. By electrically stimulating
specific regions of the lateral pallium,
they could provoke a semi-restrained
lamprey to produce movements
involving the eyes, body and mouth.
In mammals, the primary motor
region of cortex is defined as the part
of cortex that requires the least amount
of electrical current stimulation to
elicit movement. In the lamprey, the
authors found multiple areas where
stimulation with low currents could
elicit movement of different body parts,
and where the intensity of the
movement could be controlled by
varying the intensity and frequency of
stimulation.
Using fluorescent dyes that travel
from the site of injection to target areas,
Ocan˜a et al. [16] then identified
neural pathways connecting this
‘movement eliciting’ region of the
pallium to other motor centres of the
lamprey brain. Specifically, motor
pallial projections were found to
innervate the tectum deep motor
output layer, the midbrain tegmentum
and reticulospinal cells, all of them
major components in the mid- and
hindbrain motor circuits of the lamprey
and other vertebrates. Furthermore,
pallial projections were found to target
different subnuclei in the lamprey basal
ganglia and thalamus, components of
the classic cortico-striatal-thalamo-
cortical loop that has been extensively
characterized inmammals. The authors
use these two lines of evidence to
support their claim that the lamprey
pallium is not only involved in
movement control, but that the pattern
of downstream projections is
